Tamara Poling
Dermatology · Rapid City, SDNPI 1053357962
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,634 of the $6,575 with a category attached, or 70.5%. AbbVie accounts for 74.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2024 at $2,887 and has fallen 75.3% since, to $712 in 2025.
Across 204 payments — averaging $32.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Regeneron Healthcare Solutions, Inc.$353
- Sanofi$203
- Johnson & Johnson$153
- E.r. Squibb & Sons, L.L.C.$134
- Boehringer Ingelheim$120
- plus $699 from 14 others
What the payments were for
- Travel & lodging$1,62525%
- Food & beverage$4,63470%
- Education$3165%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 121 | $4,912 |
| Regeneron Healthcare Solutions, Inc. | 11 | $353 |
| Sanofi | 9 | $203 |
| Johnson & Johnson | 9 | $153 |
| E.r. Squibb & Sons, L.L.C. | 8 | $134 |
| Boehringer Ingelheim | 6 | $120 |
| Novartis | 6 | $112 |
| Galderma Laboratories, L.p. | 7 | $100 |
| Pfizer | 5 | $77 |
| Lilly USA, LLC | 4 | $66 |
| Amgen | 2 | $54 |
| Merck | 3 | $41 |
| Kyowa Kirin, Inc. | 2 | $36 |
| UCB, Inc. | 2 | $36 |
| Organon | 2 | $34 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $33 |
| Sun Pharmaceutical Industries Inc. | 2 | $33 |
| Janssen Scientific Affairs, LLC | 1 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| VYNE Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$504
How this compares
$6,575 in reported general payments places this provider in the 85th percentile of 44 dermatology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 13 | $99,537 |
| Clobetasol Propionate | 80 | $4,540 |
| Triamcinolone Acetonide | 137 | $1,865 |
| ValacyclovirValacyclovir Hcl | 34 | $1,539 |
| Doxycycline Hyclate | 25 | $1,433 |
| Metronidazole | 20 | $1,248 |
| Ketoconazole | 54 | $1,112 |
| Fluocinonide | 19 | $687 |
| Pentoxifylline | 20 | $636 |
| Betamethasone Dipropionate | 15 | $531 |
| Clindamycin Phosphate | 19 | $452 |
| Fluconazole | 17 | $427 |
| Mupirocin | 34 | $286 |
| Minoxidil | 16 | $204 |
| Spironolactone | 31 | $156 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Rapid City
- Lycia ThornburgRapid City$100K
- Maren GaulRapid City$4K
- Jason NobleRapid City$4K
- Linda FrommRapid City$3K
- Siri Knutsen LarsonRapid City$3K
- Melody EideRapid City$2K
- Kirstin HockhausenRapid City$2K
- Robert SageRapid City$1K
- Gregory WittenbergRapid City$948
- Briana HillRapid City$727
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.